Mabion S.A. (WSE:MAB)
8.26
+0.01 (0.12%)
Jan 28, 2026, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 133.34 million as of January 28, 2026. Its market cap has decreased by -17.42% in one year.
Market Cap
133.34M
Enterprise Value
131.65M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.26
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 133.34M, an increase of 43.36%. That is a compound annual growth rate of 2.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 133.34M | 18.19% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 611.53M |
| Captor Therapeutics Spolka Akcyjna | 447.83M |
| Bioceltix | 385.59M |
| BIOTON | 347.75M |
| Synthaverse | 283.08M |
| Molecure | 152.88M |
| Poltreg | 120.32M |
| Urteste | 98.96M |